SCHEMBL8047192

SCHEMBL8047192

C1CCCCCCNNCCCCCC1

nearest known ligand 0.50

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477010 1.00 ALDH1A1 (0.50) ALDH1A1
SCHEMBL30019809 1.00 ALDH1A1 (0.50) ALDH1A1
SCHEMBL30832504 1.00 ALDH1A1 (0.50) ALDH1A1
SCHEMBL123864 1.00
SCHEMBL1260534 1.00 ALDH1A1 (0.50) ALDH1A1
SCHEMBL477057 1.00
SCHEMBL477029 1.00 ALDH1A1 (0.50) ALDH1A1
SCHEMBL7770292 1.00 ALDH1A1 (0.50) ALDH1A1
SCHEMBL476999 1.00
SCHEMBL28032378 1.00 ALDH1A1 (0.50) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220211866-A1 MOMP TELONANOPARTICLES, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS LAWRENCE LIVERMORE NATIONAL SECURITY, LLC 2022-07-07 US disclosed
US-10870150-B2 Long and high resolution structures formed by additive manufacturing techniques Seurat Technologies, Inc. (US) 2020-12-22 US disclosed
EP-0600718-B1 Secondary battery CANON KK (JP) 2000-04-26 EP disclosed
EP-0809314-A2 Positive active material, method of manufacturing and secondary battery using the same CANON KABUSHIKI KAISHA (JP) 1997-11-26 EP disclosed
US-4278784-A SILICONE CONTAINING CRYPTATE ETHER WESTERN ELECTRIC COMPANY, INC. (US) 1981-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220211866-A1 MOMP TELONANOPARTICLES, AND RELATED COMPOSITIONS, METHODS AND SYSTEMS CETP, PCTP, MTTP ALDH1A1 4872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.